webinar register page

Webinar banner
Tribe Public Event - Thursday, Nov. 17, 2022 - InMed Pharmaceuticals (NASDAQ: INM) "Exploring The Neuroprotective Qualities of Rare Cannabinoids"
We are excited to be hosting Tribe Public's Next Webinar Presentation and Q&A Event which will be held Thursday, November 17 (8:30 am PT/ 11:30 am ET). Our events are efficient and are approximately 30 minutes in duration.

Eric A. Adams, CEO & Eric C. Hsu, PhD, Senior Vice President, Pre-Clinical Research & Development of InMed Pharmaceuticals (NASDAQ: INM) will deliver a presentation titled "Exploring The Neuroprotective Qualities of Rare Cannabinoids." They will be also be available for a 5-10 minute Q&A session at the end of the presentation. Send Questions to email: research@tribepublic.com.

InMed Pharmaceuticals is a global leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, including clinical and preclinical programs targeting the treatment of diseases with high unmet medical needs. They also have significant know-how in developing proprietary manufacturing approaches to produce cannabinoids for various market sectors.

By registering for this event automatically be joining Tribe Public & be agreeing to receive future FREE invitations for out events.

View Disclaimer: https://tribepublic.com/disclaimers.

Nov 17, 2022 08:30 AM in Pacific Time (US and Canada)

Webinar logo
Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: .